ProShares UltraShort Bloomberg Natrl Gas

Defiance Daily Short Digitizing the Economy ETF

ProShares Bitcoin Strategy ETF

VS TR -1x Short VIX Futures ETF

Direxion Daily Semicondct Bull 3X ETF

Direxion Daily Technology Bull 3X ETF

ProShares UltraShort Silver

ProShares UltraPro QQQ

ARK Innovation ETF

Direxion Daily S&P Biotech Bull 3X ETF

Guggenheim Solar ETF

ProShares Ultra Bloomberg Natural Gas

SPDR S&P Regional Banking ETF

VS TR 2x Long VIX Futures ETF

ProShares Trust ProShares Short Bitcoin Strategy ETF

Direxion Daily Semicondct Bear 3X ETF

ProShares Ultra VIX Short-Term Futures

ProShares Ultra Silver

United States Natural Gas

ProShares UltraPro Short QQQ

Urban Outfitters Inc. Common Stock

Snowflake Inc. Class A Common Stock

AgEagle Aerial Systems Inc. Common Stock

MINISO Group Holding Limited American Depositary Shares each representing four Ordinary Shares

CleanSpark Inc. Common Stock

Aquestive Therapeutics Inc. Common Stock

ChargePoint Holdings Inc. Common Stock

Marathon Digital Holdings Inc. Common Stock

Rigetti Computing Inc. Common Stock

Dana Incorporated Common Stock

Fastenal Company Common Stock

Edible Garden AG Incorporated Common Stock

Hims & Hers Health Inc. Class A Common Stock

XPeng Inc. American depositary shares each representing two Class A ordinary shares

SolarEdge Technologies Inc. Common Stock

Enphase Energy Inc. Common Stock

New Fortress Energy Inc. Class A Common Stock

Virgin Galactic Holdings Inc. Common Stock

UnitedHealth Group Incorporated Common Stock (DE)

Ralph Lauren Corporation Common Stock

Click here to get full coverage on Insider Buying: McNulty Martin D. Jr. Acquires Shares of Acacia Research Corp (ACTG) - GuruFocus

Insider Buying: McNulty Martin D. Jr. Acquires Shares of Acacia Research Corp (ACTG)  GuruFocus

Insider Buying: McNulty Martin D. Jr. Acquires Shares of Acacia Research Corp (ACTG) - GuruFocus

Click here to get full coverage on ACTG Presents Data from Mpox Study STOMP at CROI - GlobeNewswire

ACTG Presents Data from Mpox Study STOMP at CROI  GlobeNewswire

ACTG Presents Data from Mpox Study STOMP at CROI - GlobeNewswire

Click here to get full coverage on Acacia Research Corp (ACTG) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Acacia Research Corp (ACTG) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...  Yahoo Finance

Acacia Research Corp (ACTG) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Acacia Research (NASDAQ:ACTG) Upgraded by StockNews.com to Hold Rating - MarketBeat

Acacia Research (NASDAQ:ACTG) Upgraded by StockNews.com to Hold Rating  MarketBeat

Acacia Research (NASDAQ:ACTG) Upgraded by StockNews.com to Hold Rating - MarketBeat

Click here to get full coverage on Acacia Research Sets Key Q1 2025 Earnings Date: What Industrial Tech Investors Should Watch - Stock Titan

Acacia Research Sets Key Q1 2025 Earnings Date: What Industrial Tech Investors Should Watch  Stock Titan

Acacia Research Sets Key Q1 2025 Earnings Date: What Industrial Tech Investors Should Watch - Stock Titan

Click here to get full coverage on Investors Still Aren't Entirely Convinced By Acacia Research Corporation's (NASDAQ:ACTG) Revenues Despite 26% Price Jump - simplywall.st

Investors Still Aren't Entirely Convinced By Acacia Research Corporation's (NASDAQ:ACTG) Revenues Despite 26% Price Jump  simplywall.st

Investors Still Aren't Entirely Convinced By Acacia Research Corporation's (NASDAQ:ACTG) Revenues Despite 26% Price Jump - simplywall.st

Click here to get full coverage on ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV (Cytomegalovirus) - GlobeNewswire

ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV (Cytomegalovirus)  GlobeNewswire

ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV (Cytomegalovirus) - GlobeNewswire

Click here to get full coverage on Acacia Research Corporation 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:ACTG) - Seeking Alpha

Acacia Research Corporation 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:ACTG)  Seeking Alpha

Acacia Research Corporation 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:ACTG) - Seeking Alpha

Click here to get full coverage on NIH Grant Cuts Threaten Progress in HIV Prevention and Treatment - POZ - Health, Life and HIV

NIH Grant Cuts Threaten Progress in HIV Prevention and Treatment  POZ - Health, Life and HIV

NIH Grant Cuts Threaten Progress in HIV Prevention and Treatment - POZ - Health, Life and HIV

Click here to get full coverage on Acacia Research Corporation (NASDAQ:ACTG) Q1 2025 Earnings Call Transcript - Insider Monkey

Acacia Research Corporation (NASDAQ:ACTG) Q1 2025 Earnings Call Transcript  Insider Monkey

Acacia Research Corporation (NASDAQ:ACTG) Q1 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Acacia Research: Q1 Earnings Snapshot - The Washington Post

Acacia Research: Q1 Earnings Snapshot  The Washington Post

Acacia Research: Q1 Earnings Snapshot - The Washington Post

Click here to get full coverage on Raymond James Financial Inc. Invests $74,000 in Acacia Research Co. (NASDAQ:ACTG) - Defense World

Raymond James Financial Inc. Invests $74,000 in Acacia Research Co. (NASDAQ:ACTG)  Defense World

Raymond James Financial Inc. Invests $74,000 in Acacia Research Co. (NASDAQ:ACTG) - Defense World

Click here to get full coverage on Acacia Research Corporation Reports First Quarter 2025 Financial Results - Stock Titan

Acacia Research Corporation Reports First Quarter 2025 Financial Results  Stock Titan

Acacia Research Corporation Reports First Quarter 2025 Financial Results - Stock Titan

Click here to get full coverage on ACTG Launches Second HIV Cure Clinical Trial in Africa - GlobeNewswire

ACTG Launches Second HIV Cure Clinical Trial in Africa  GlobeNewswire

ACTG Launches Second HIV Cure Clinical Trial in Africa - GlobeNewswire

Click here to get full coverage on ACTG Presents Study at CROI Demonstrating Increased Risk of - GlobeNewswire

ACTG Presents Study at CROI Demonstrating Increased Risk of  GlobeNewswire

ACTG Presents Study at CROI Demonstrating Increased Risk of - GlobeNewswire

Click here to get full coverage on ACTG Presents Important Findings from REPRIEVE at CROI 2025 - GlobeNewswire

ACTG Presents Important Findings from REPRIEVE at CROI 2025  GlobeNewswire

ACTG Presents Important Findings from REPRIEVE at CROI 2025 - GlobeNewswire

Click here to get full coverage on ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER - GlobeNewswire

ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER  GlobeNewswire

ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER - GlobeNewswire

Click here to get full coverage on ACTG Announces Publication of BEe-HIVe Trial in JAMA - GlobeNewswire

ACTG Announces Publication of BEe-HIVe Trial in JAMA  GlobeNewswire

ACTG Announces Publication of BEe-HIVe Trial in JAMA - GlobeNewswire

Click here to get full coverage on ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa - GlobeNewswire

ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa  GlobeNewswire

ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa - GlobeNewswire

Click here to get full coverage on ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular Events and Abacavir Use Among People Living with HIV - GlobeNewswire

ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular Events and Abacavir Use Among People Living with HIV  GlobeNewswire

ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular Events and Abacavir Use Among People Living with HIV - GlobeNewswire

Click here to get full coverage on Acacia Research Corporation Reports Fourth Quarter and Year End 2024 Financial Results - TradingView

Acacia Research Corporation Reports Fourth Quarter and Year End 2024 Financial Results  TradingView

Acacia Research Corporation Reports Fourth Quarter and Year End 2024 Financial Results - TradingView

Click here to get full coverage on Acacia Research Co. (NASDAQ:ACTG) Shares Acquired by Wells Fargo & Company MN - Defense World

Acacia Research Co. (NASDAQ:ACTG) Shares Acquired by Wells Fargo & Company MN  Defense World

Acacia Research Co. (NASDAQ:ACTG) Shares Acquired by Wells Fargo & Company MN - Defense World

Click here to get full coverage on Acacia Research Co. (NASDAQ:ACTG) Position Increased by Barclays PLC - Defense World

Acacia Research Co. (NASDAQ:ACTG) Position Increased by Barclays PLC  Defense World

Acacia Research Co. (NASDAQ:ACTG) Position Increased by Barclays PLC - Defense World

Click here to get full coverage on Acacia Research Co. (NASDAQ:ACTG) Position Boosted by Dimensional Fund Advisors LP - Defense World

Acacia Research Co. (NASDAQ:ACTG) Position Boosted by Dimensional Fund Advisors LP  Defense World

Acacia Research Co. (NASDAQ:ACTG) Position Boosted by Dimensional Fund Advisors LP - Defense World

Click here to get full coverage on 30 Years Ago, Pregnant Women of Color Fought for a Major Breakthrough in HIV Prevention - TheBody

30 Years Ago, Pregnant Women of Color Fought for a Major Breakthrough in HIV Prevention  TheBody

30 Years Ago, Pregnant Women of Color Fought for a Major Breakthrough in HIV Prevention - TheBody

Click here to get full coverage on ACTG begins trial of three immune-based therapy combinations for HIV cure - Clinical Trials Arena

ACTG begins trial of three immune-based therapy combinations for HIV cure  Clinical Trials Arena

ACTG begins trial of three immune-based therapy combinations for HIV cure - Clinical Trials Arena

Click here to get full coverage on Broadly Neutralizing Antibodies Evaluated in Many HIV Cure Strategies - POZ - Health, Life and HIV

Broadly Neutralizing Antibodies Evaluated in Many HIV Cure Strategies  POZ - Health, Life and HIV

Broadly Neutralizing Antibodies Evaluated in Many HIV Cure Strategies - POZ - Health, Life and HIV

Click here to get full coverage on Emory/ACTG celebrate decades of game-changing HIV/AIDS clinical trials | Emory University | Atlanta GA - Emory University

Emory/ACTG celebrate decades of game-changing HIV/AIDS clinical trials | Emory University | Atlanta GA  Emory University

Emory/ACTG celebrate decades of game-changing HIV/AIDS clinical trials | Emory University | Atlanta GA - Emory University

Click here to get full coverage on Figure 3. Graph showing pgRNA biphasic decline curve after HBV... - ResearchGate

Figure 3. Graph showing pgRNA biphasic decline curve after HBV...  ResearchGate

Figure 3. Graph showing pgRNA biphasic decline curve after HBV... - ResearchGate

Click here to get full coverage on ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure - Yahoo Finance

ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure  Yahoo Finance

ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure - Yahoo Finance

Click here to get full coverage on ACTG to make 29 presentations at CROI 2023 - EurekAlert!

ACTG to make 29 presentations at CROI 2023  EurekAlert!

ACTG to make 29 presentations at CROI 2023 - EurekAlert!

Click here to get full coverage on Treasure Hunt: 7 Penny Stocks Wall Street Hasn’t Discovered Yet - InvestorPlace

Treasure Hunt: 7 Penny Stocks Wall Street Hasn’t Discovered Yet  InvestorPlace

Treasure Hunt: 7 Penny Stocks Wall Street Hasn’t Discovered Yet - InvestorPlace

Click here to get full coverage on U.S. clinical trial evaluating antiviral for monkeypox begins - National Institutes of Health (NIH) (.gov)

U.S. clinical trial evaluating antiviral for monkeypox begins  National Institutes of Health (NIH) (.gov)

U.S. clinical trial evaluating antiviral for monkeypox begins - National Institutes of Health (NIH) (.gov)

Click here to get full coverage on ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 Oral Antiviral Agent S‑217622 - Business Wire

ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 Oral Antiviral Agent S‑217622  Business Wire

ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 Oral Antiviral Agent S‑217622 - Business Wire

Click here to get full coverage on Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis - The New England Journal of Medicine

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis  The New England Journal of Medicine

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis - The New England Journal of Medicine

Click here to get full coverage on ACTG CROI Presentations Show That Semaglutide Improves - GlobeNewswire

ACTG CROI Presentations Show That Semaglutide Improves  GlobeNewswire

ACTG CROI Presentations Show That Semaglutide Improves - GlobeNewswire

Click here to get full coverage on Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study - The Lancet

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study  The Lancet

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study - The Lancet

Click here to get full coverage on A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet

A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial  The Lancet

A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet

Click here to get full coverage on Figure 1. Selected portion of AIDS Clinical Trial Group (ACTG)... - ResearchGate

Figure 1. Selected portion of AIDS Clinical Trial Group (ACTG)...  ResearchGate

Figure 1. Selected portion of AIDS Clinical Trial Group (ACTG)... - ResearchGate

Click here to get full coverage on Dr. Elizabeth Connick Wins National Women’s Health Award for HIV/AIDS Research, Advocacy - The University of Arizona Health Sciences

Dr. Elizabeth Connick Wins National Women’s Health Award for HIV/AIDS Research, Advocacy  The University of Arizona Health Sciences

Dr. Elizabeth Connick Wins National Women’s Health Award for HIV/AIDS Research, Advocacy - The University of Arizona Health Sciences

Click here to get full coverage on Faculty Spotlight: Stephen Carter, Accounting Department - 2023-24 - Leavey School of Business - Santa Clara University

Faculty Spotlight: Stephen Carter, Accounting Department - 2023-24 - Leavey School of Business  Santa Clara University

Faculty Spotlight: Stephen Carter, Accounting Department - 2023-24 - Leavey School of Business - Santa Clara University

Click here to get full coverage on A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter - The New England Journal of Medicine

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter  The New England Journal of Medicine

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter - The New England Journal of Medicine

Click here to get full coverage on NIH announces restructured HIV clinical trials networks - National Institutes of Health (NIH) (.gov)

NIH announces restructured HIV clinical trials networks  National Institutes of Health (NIH) (.gov)

NIH announces restructured HIV clinical trials networks - National Institutes of Health (NIH) (.gov)

Click here to get full coverage on Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment - The New England Journal of Medicine

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment  The New England Journal of Medicine

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment - The New England Journal of Medicine

Click here to get full coverage on Three Novel Immune-based Therapies for HIV Cure Launch Clinical Trial - Vax-Before-Travel

Three Novel Immune-based Therapies for HIV Cure Launch Clinical Trial  Vax-Before-Travel

Three Novel Immune-based Therapies for HIV Cure Launch Clinical Trial - Vax-Before-Travel

Click here to get full coverage on One-month tuberculosis prophylaxis as effective as nine-month regimen for people living with HIV - National Institutes of Health (NIH) (.gov)

One-month tuberculosis prophylaxis as effective as nine-month regimen for people living with HIV  National Institutes of Health (NIH) (.gov)

One-month tuberculosis prophylaxis as effective as nine-month regimen for people living with HIV - National Institutes of Health (NIH) (.gov)

Click here to get full coverage on Celebrating Faculty - Top Stories - Leavey School of Business - Santa Clara University

Celebrating Faculty - Top Stories - Leavey School of Business  Santa Clara University

Celebrating Faculty - Top Stories - Leavey School of Business - Santa Clara University

Click here to get full coverage on Business Faculty Awards - News - Leavey School of Business - SCU - Santa Clara University

Business Faculty Awards - News - Leavey School of Business - SCU  Santa Clara University

Business Faculty Awards - News - Leavey School of Business - SCU - Santa Clara University

Click here to get full coverage on Actg. IGP orders police to take action on those who failed to file campaign finance reports - The Island.lk

Actg. IGP orders police to take action on those who failed to file campaign finance reports  The Island.lk

Actg. IGP orders police to take action on those who failed to file campaign finance reports - The Island.lk

Click here to get full coverage on Acacia Research Acquires Majority Stake in Benchmark Energy - Business Wire

Acacia Research Acquires Majority Stake in Benchmark Energy  Business Wire

Acacia Research Acquires Majority Stake in Benchmark Energy - Business Wire

Click here to get full coverage on Justice Laffar Tahir named Actg. President of Appeal Court - Sri Lanka Mirror

Justice Laffar Tahir named Actg. President of Appeal Court  Sri Lanka Mirror

Justice Laffar Tahir named Actg. President of Appeal Court - Sri Lanka Mirror

Click here to get full coverage on Long-acting ART in people with adherence challenges - CATIE.ca

Long-acting ART in people with adherence challenges  CATIE.ca

Long-acting ART in people with adherence challenges - CATIE.ca

Click here to get full coverage on Cracking the pear genome: How students helped unlock a new tool for the pear industry - Phys.org

Cracking the pear genome: How students helped unlock a new tool for the pear industry  Phys.org

Cracking the pear genome: How students helped unlock a new tool for the pear industry - Phys.org

Click here to get full coverage on Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis - The New England Journal of Medicine

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis  The New England Journal of Medicine

Acacia Research Corporation (ACTG)

Price Chart

Key Statistics

Technicals

About ACTG

Latest News

Insider Buying: McNulty Martin D. Jr. Acquires Shares of Acacia Research Corp (ACTG) - GuruFocus

ACTG Presents Data from Mpox Study STOMP at CROI - GlobeNewswire

Acacia Research Corp (ACTG) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers